ABT
Abbott Laboratories
102.60$
+0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.3% | +8.0% | +73.9% | +13.1% | -2.6% | +28.8% | +33.3% | -9.0% | -24.2% | +17.9% | +11.8% | |
| – | -4.9% | -8.1% | +123.3% | +8.5% | -8.1% | +10.4% | +6.3% | -7.7% | -0.7% | -0.8% | -3.2% | |
| – | +18.7% | +6.2% | +31.0% | +17.5% | +8.8% | +5.2% | +17.2% | +7.0% | -6.0% | +4.5% | -1.3% | |
| – | -1,143.6% | – | -146.8% | – | -9.6% | -6.2% | +17.2% | +7.0% | – | – | – | |
| – | – | – | – | -107.7% | – | – | – | – | – | – | – | |
| – | +3.1% | +1.0% | +1.2% | +22.8% | +17.5% | +32.9% | -13.4% | -5.7% | +23.9% | +0.2% | -1.6% | |
| – | – | -161.1% | +3,778.2% | -85.9% | +33.8% | +22.0% | -9.3% | -13.3% | +80.1% | -25.4% | +3.6% | |
| – | +7.5% | +6.7% | +20.1% | +6.8% | +15.0% | +12.8% | +25.1% | +3.3% | +7.5% | +7.9% | +7.3% | |
| – | +1.9% | -76.7% | +58.4% | -71.2% | +201.7% | -43.9% | +470.5% | +65.1% | -67.7% | +5.5% | -31.0% | |
| – | +49.7% | +1,032.1% | -122.7% | +187.2% | -81.1% | -96.9% | +396.0% | – | -5,366.0% | -78.3% | +200.6% | |
| – | -18.5% | – | -147.4% | +96.8% | -58.7% | -35.2% | +97.7% | +39.0% | -7.1% | -23.8% | +16.7% | |
| – | +59.5% | +1,351.9% | -167.6% | – | – | +18,512.5% | -0.6% | -97.2% | -3,697.6% | – | +25.8% | |
| – | -28.6% | +12.2% | +113.0% | +10.6% | -8.3% | +27.3% | +51.1% | -9.8% | -35.2% | +25.5% | +16.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.